Oncolytic Adenovirus-Based Immunotherapy for Malignant Mesothelioma: Preclinical Advances and Future Perspectives
Authors
Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy
Warsaw University of Technology, Warsaw, Poland
Department of Virology, National Institute of Public Health NIH – National Research Institute, Warsaw, Poland
Valo Therapeutics, Helsinki, Finland
Language: English, Polish
Page range: 46 - 50
Submitted on: Mar 23, 2025
Accepted on: May 30, 2025
Published on: Jul 8, 2025
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2025 Mariangela Garofalo, Monika Staniszewska, Stefano Salmaso, Paolo Caliceti, Lukasz Kuryk, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.